A Canadian manufacturer of positron emission tomography equipment has received FDA’s OK to market a small-footprint scanner that images targeted organs bearing radiotracers at close range.
Announcing the clearance July 18, Thunder Bay-based Radialis said its new PET system is designed to supply expanded views of molecular activity, yielding functional organ images with high spatial resolution.
“Able to visualize any positron-emitting radiotracer, the system is particularly promising for imaging novel radiotracers targeting biomarkers in a specific organ,” the company says, adding that the machine’s relatively diminutive size is intended to accommodate sites looking to complement PET/CT capabilities in existing nuclear medicine service lines.
Radialis says it bases its technology on research conducted at Thunder Bay’s Lakehead University.
Full announcement here.
Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.